93
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Chronic Obstructive Pulmonary Disease (COPD) in Population Studies in Russia and Norway: Comparison of Prevalence, Awareness and Management

ORCID Icon, , , , , ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 1353-1368 | Published online: 14 May 2021

References

  • Starodubov VI, Marczak LB, Varavikova E, et al. The burden of disease in Russia from 1980 to 2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2018;392(10153):1138–1146. doi:10.1016/S0140-6736(18)31485-5
  • Finkelstein J, Cha E, Scharf SM. Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity. Int J Chron Obstruct Pulmon Dis. 2009;4:337–349. doi:10.2147/COPD.S6400
  • Anecchino C, Rossi E, Fanizza C, et al. Prevalence of chronic obstructive pulmonary disease and pattern of comorbidities in a general population. Int J Chron Obstruct Pulmon Dis. 2007;2(4):567–574.
  • Berry CE, Wise RA. Mortality in COPD: causes, risk factors, and prevention. COPD. 2010;7(5):375–382. doi:10.3109/15412555.2010.510160
  • Sin DD, Anthonisen NR, Soriano JB, Agusti AG. Mortality in COPD: role of comorbidities. Eur Respir J. 2006;28(6):1245–1257. doi:10.1183/09031936.00133805
  • Hansell AL, Walk JA, Soriano JB. What do chronic obstructive pulmonary disease patients die from? A multiple cause coding analysis. Eur Respir J. 2003;22(5):809. doi:10.1183/09031936.03.00031403
  • Giovino GA, Mirza SA, Samet JM, et al. Tobacco use in 3 billion individuals from 16 countries: an analysis of nationally representative cross-sectional household surveys. Lancet. 2012;380(9842):668–679. doi:10.1016/S0140-6736(12)61085-X
  • Mazitova NN, Saveliev AA, Berheeva ZM, Amirov NK. COPD and occupation: a retrospective cohort study of industrial workers. Arh Hig Rada Toksikol. 2012;63(3):345–356. doi:10.2478/10004-1254-63-2012-2178
  • Townsend N, Wilson L, Bhatnagar P, Wickramasinghe K, Rayner M, Nichols M. Cardiovascular disease in Europe: epidemiological update 2016. Eur Heart J. 2016;37(42):3232–3245. doi:10.1093/eurheartj/ehw334
  • Cook S, Quint JK, Vasiljev M, Leon DA. Self-reported symptoms of chronic cough and breathlessness in working-age men in the city of Izhevsk, Russia: associations with cardiovascular disease risk factors and comorbidities. BMJ Open Respir Res. 2015;2(1):e000104–e. doi:10.1136/bmjresp-2015-000104
  • Chuchalin AG, Khaltaev N, Antonov NS, et al. Chronic respiratory diseases and risk factors in 12 regions of the Russian Federation. Int J Chron Obstruct Pulmon Dis. 2014;9:963–974. doi:10.2147/COPD.S67283
  • Vietri J, Ertl S, Isherwood G, Bevelskiy AS. PRS52 - symptoms of COPD in urban Russia among adults 40 years and older. Value Health. 2013;16(7):A375. doi:10.1016/j.jval.2013.08.303
  • Andreeva E, Pokhaznikova M, Lebedev A, Moiseeva I, Kutznetsova O, Degryse JM. The prevalence of chronic obstructive pulmonary disease by the global lung initiative equations in North-Western Russia. Respiration. 2016;91(1):43–55. doi:10.1159/000442887
  • Kovalkova NA, Logvinenko NI, Voevoda MI. The frequency of internal disease at airflow obstruction according to screening of Siberian urban population (HAPIEE Study) [Russia]. Bull SB RAMS. 2013;33(6).
  • Bikbov MM, Kazakbaeva GM, Zainullin RM, et al. Prevalence, awareness, and associated factors of airflow obstruction in russia: the Ural Eye and Medical Study. Front Public Health. 2019;7(350). doi:10.3389/fpubh.2019.00350.
  • Rabe KF, Watz H. Chronic obstructive pulmonary disease. Lancet. 2017;389(10082):1931–1940. doi:10.1016/S0140-6736(17)31222-9
  • Adeloye D, Chua S, Lee C, et al. Global and regional estimates of COPD prevalence: systematic review and meta-analysis. J Glob Health. 2015;5(2):20415. doi:10.7189/jogh.05.020415
  • Buist AS, McBurnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study. Lancet. 2007;370(9589):741–750. doi:10.1016/S0140-6736(07)61377-4
  • Bhatta L, Leivseth L, Mai XM, et al. Prevalence and trend of COPD from 1995–1997 to 2006–2008: the HUNT Study, Norway. Respir Med. 2018;138:50–56. doi:10.1016/j.rmed.2018.03.020
  • Melbye H, Helgeland J, Karlstad O, et al. Is the disease burden from COPD in Norway falling off? A study of time trends in three different data sources. Int J Chron Obstruct Pulmon Dis. 2020;15:323–334. doi:10.2147/COPD.S235106
  • Cook S, Malyutina S, Kudryavtsev A, et al. Know your heart: rationale, design and conduct of a cross-sectional study of cardiovascular structure, function and risk factors in 4500 men and women aged 35–69 years from two Russian cities, 2015–18 [version 3; peer review: 3 approved]. Wellcome Open Res. 2018;3(67):67. doi:10.12688/wellcomeopenres.14619.1
  • Jacobsen BK, Eggen AE, Mathiesen EB, Wilsgaard T, Njolstad I. Cohort profile: the Tromso Study. Int J Epidemiol. 2012;41(4):961–967. doi:10.1093/ije/dyr049
  • Quanjer PH, Stanojevic S, Cole TJ, et al. Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations. Eur Respir J. 2012;40(6):1324–1343. doi:10.1183/09031936.00080312
  • Quanjer PH, Stanojevic S, Cole TJ, Stocks J. GLI-2012 Desktop Software for Large Data Sets. 2013.
  • Stenton C. The MRC breathlessness scale. Occup Med (Chic Ill). 2008;58(3):226–227. doi:10.1093/occmed/kqm162
  • Global Initiative for Chronic Obstructive Lung Disease. Pocket Guide to COPD Management, Diagnosis and Prevention: A Guide for Health Care Professionals. 2020.
  • WHO Collaborating Centre for Drug Statistics Methodology; 2019. Available from: https://www.whocc.no/. Accessed March 31, 2021.
  • Shkolnikov VM, Churilova E, Jdanov DA, et al. Time trends in smoking in Russia in the light of recent tobacco control measures: synthesis of evidence from multiple sources. BMC Public Health. 2020;20(1):378. doi:10.1186/s12889-020-08464-4
  • Woodruff PG, Barr RG, Bleecker E, et al. Clinical significance of symptoms in smokers with preserved pulmonary function. N Engl J Med. 2016;374(19):1811–1821. doi:10.1056/NEJMoa1505971
  • Martinez CH, Murray S, Barr RG, et al. Respiratory symptoms items from the COPD assessment test identify ever-smokers with preserved lung function at higher risk for poor respiratory outcomes. An analysis of the subpopulations and intermediate outcome measures in COPD Study cohort. Ann Am Thorac Soc. 2017;14(5):636–642. doi:10.1513/AnnalsATS.201610-815OC
  • Opina MTD, Nicklas BJ, Lovato JF, Files DC, Kritchevsky SB, Moore WC. Association of symptoms of obstructive lung disease and all-cause mortality in older adult smokers. J Am Geriatr Soc. 2019;67(10):2116–2122. doi:10.1111/jgs.16052
  • The Tromsø Study: Tromsøundersøkelsen. The Tromsø Study Tromsø 7; 2020. Available from: https://uit.no/forskning/forskningsgrupper/sub?p_document_id=367276&sub_id=503778. forskning=research (Norwegian) forskningsgrupper= research group (Norwegian) Accessed March 23, 2020.
  • Norwegian prescription database Norwegian Institute of Public Health (NIPH); 2020. Available from: http://www.norpd.no. Accessed March 31, 2021.
  • Know your heart: Узнай своё сердце “Know Your Heart” (Russian translation of the study name); 2020. Available from: https://metadata.knowyourheart.science/. Accessed March 23, 2020.